Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus. 2014

Sun Young Yim, and Soon Ho Um, and Jin Young Jung, and Yeon Seok Seo, and Hyung Joon Yim, and Ho Sang Ryu, and Hoon Jai Chun, and Yoon Tae Jeen, and Chang Duck Kim, and Bora Keum, and Hong Sik Lee
Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.

BACKGROUND Inactive and active phases of hepatitis B e antigen-negative chronic hepatitis B virus (HBV) infection are diagnosed by serum HBV DNA levels, with cutoff at 2000 IU/mL. However, it is difficult to distinguish inactive carriers at a single time point because HBV DNA levels can transiently decrease to <2000 IU/mL even in noninactive carriers. OBJECTIVE We aimed to establish the role of serum hepatitis B surface antigen (HBsAg) in identifying "true inactive carriers" among treatment-naive genotype C HBV-infected patients with low viremia. METHODS A total of 133 hepatitis B e antigen-negative carriers with serum HBV DNA levels of <2000 IU/mL and normal alanine aminotransferase levels were enrolled and followed up for >12 months. RESULTS Forty patients (30.1%) were classified as noninactive carriers (HBV DNA ≥2000 IU/mL and/or alanine aminotransferase >40 IU/L) during 12 months from enrollment. No baseline serum HBV DNA levels could identify true inactive carriers with 100% specificity, whereas baseline serum HBsAg levels (50 IU/mL) identified true inactive carriers with 100% specificity and 29% detection rate. Detection rate increased when different cutoff levels were applied to different age groups according to median age (46 y). It was comparable in both younger and older groups (37.2% vs. 38%) even when HBsAg cutoff level was increased in the former (400 vs. 50 IU/mL). Furthermore, none reversed to noninactive phase during long-term follow-up when these cutoff levels were applied. CONCLUSIONS Baseline serum HBsAg levels at a single time point can identify persistently true inactive carriers, with different cutoff levels according to age.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006513 Hepatitis B e Antigens A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. HBeAg,Hepatitis B e Antigen,Hepatitis Be Antigen,e Antigen,e Antigens,HBe Ag-1,HBe Ag-2,Hepatitis Be Antigens,Antigen, Hepatitis Be,Antigen, e,Antigens, Hepatitis Be,Antigens, e,Be Antigen, Hepatitis,Be Antigens, Hepatitis
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B

Related Publications

Sun Young Yim, and Soon Ho Um, and Jin Young Jung, and Yeon Seok Seo, and Hyung Joon Yim, and Ho Sang Ryu, and Hoon Jai Chun, and Yoon Tae Jeen, and Chang Duck Kim, and Bora Keum, and Hong Sik Lee
August 2010, Gastroenterology,
Sun Young Yim, and Soon Ho Um, and Jin Young Jung, and Yeon Seok Seo, and Hyung Joon Yim, and Ho Sang Ryu, and Hoon Jai Chun, and Yoon Tae Jeen, and Chang Duck Kim, and Bora Keum, and Hong Sik Lee
July 1998, Journal of clinical microbiology,
Sun Young Yim, and Soon Ho Um, and Jin Young Jung, and Yeon Seok Seo, and Hyung Joon Yim, and Ho Sang Ryu, and Hoon Jai Chun, and Yoon Tae Jeen, and Chang Duck Kim, and Bora Keum, and Hong Sik Lee
March 2017, Medicine,
Sun Young Yim, and Soon Ho Um, and Jin Young Jung, and Yeon Seok Seo, and Hyung Joon Yim, and Ho Sang Ryu, and Hoon Jai Chun, and Yoon Tae Jeen, and Chang Duck Kim, and Bora Keum, and Hong Sik Lee
February 2022, Journal of clinical medicine,
Sun Young Yim, and Soon Ho Um, and Jin Young Jung, and Yeon Seok Seo, and Hyung Joon Yim, and Ho Sang Ryu, and Hoon Jai Chun, and Yoon Tae Jeen, and Chang Duck Kim, and Bora Keum, and Hong Sik Lee
November 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Sun Young Yim, and Soon Ho Um, and Jin Young Jung, and Yeon Seok Seo, and Hyung Joon Yim, and Ho Sang Ryu, and Hoon Jai Chun, and Yoon Tae Jeen, and Chang Duck Kim, and Bora Keum, and Hong Sik Lee
November 2021, Internal medicine (Tokyo, Japan),
Sun Young Yim, and Soon Ho Um, and Jin Young Jung, and Yeon Seok Seo, and Hyung Joon Yim, and Ho Sang Ryu, and Hoon Jai Chun, and Yoon Tae Jeen, and Chang Duck Kim, and Bora Keum, and Hong Sik Lee
May 2016, World journal of hepatology,
Sun Young Yim, and Soon Ho Um, and Jin Young Jung, and Yeon Seok Seo, and Hyung Joon Yim, and Ho Sang Ryu, and Hoon Jai Chun, and Yoon Tae Jeen, and Chang Duck Kim, and Bora Keum, and Hong Sik Lee
September 2020, Journal of viral hepatitis,
Sun Young Yim, and Soon Ho Um, and Jin Young Jung, and Yeon Seok Seo, and Hyung Joon Yim, and Ho Sang Ryu, and Hoon Jai Chun, and Yoon Tae Jeen, and Chang Duck Kim, and Bora Keum, and Hong Sik Lee
June 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Sun Young Yim, and Soon Ho Um, and Jin Young Jung, and Yeon Seok Seo, and Hyung Joon Yim, and Ho Sang Ryu, and Hoon Jai Chun, and Yoon Tae Jeen, and Chang Duck Kim, and Bora Keum, and Hong Sik Lee
February 1981, Clinical and experimental immunology,
Copied contents to your clipboard!